2021
DOI: 10.1016/j.mayocp.2020.07.037
|View full text |Cite
|
Sign up to set email alerts
|

Adherence to Chronic Kidney Disease Screening Guidelines Among Patients With Type 2 Diabetes in a US Administrative Claims Database

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
20
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 30 publications
(34 citation statements)
references
References 21 publications
3
20
0
Order By: Relevance
“…A Joinpoint was identified for neuropathy in age-band 1, the positive and statistically significant APC in the later segment indicates an increase in neuropathy event rates between 2017–2020. Process measures for diabetes care of patients were comparable to similar measures across the United States and Japan [ 32 34 ]. In this study, the process measures exhibited some variation but did not demonstrate marked increase over the observation period ( S4 Table ).…”
Section: Resultsmentioning
confidence: 99%
“…A Joinpoint was identified for neuropathy in age-band 1, the positive and statistically significant APC in the later segment indicates an increase in neuropathy event rates between 2017–2020. Process measures for diabetes care of patients were comparable to similar measures across the United States and Japan [ 32 34 ]. In this study, the process measures exhibited some variation but did not demonstrate marked increase over the observation period ( S4 Table ).…”
Section: Resultsmentioning
confidence: 99%
“…Other investigations assessing CKD monitoring in a T2D population with a previous CKD diagnosis also found that uACR was largely undertested despite clinical practice guideline recommendations. 30,31 The severe undertesting of uACR observed in this study and others raises concerns about management of these patients, especially when the observed association between a low uACR testing rate and higher state-level health care costs are considered.…”
Section: Patterns By Age Racial Group and Ckd Stagementioning
confidence: 72%
“…1,23 Despite the importance of identifying and managing albuminuria, insufficient testing of uACR has been noted in patients with T2D. 7,[30][31][32][33] However, this has not been well evaluated in patients with CKD and T2D, in whom albuminuria is prevalent. In addition, neither variations in testing adequacy across the United States in T2D and CKD nor the economic burdens associated with inadequate testing have been studied.…”
Section: Discussionmentioning
confidence: 99%